In conclusion, detection of TWIST1 overexpression and stem-cell (CD24, CD44, ALDH1) transcripts in the EpCAM+ CTC fraction provides prognostic information in early stage breast cancer patients. This evidence concerns the gene EPCAM and breast cancer.